Chicago, IL 的 神經膠質瘤 臨床試驗
13 項針對 神經膠質瘤 的研究正在 Chicago（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
招募中1/2 期
- University of Chicago Comprehensive Cancer Center, Chicago
Targeted Pediatric High-Grade Glioma Therapy
招募中觀察性研究
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Study of Olutasidenib and Temozolomide in HGG
招募中2 期
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
招募中3 期
- University of Chicago, Chicago
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
招募中2 期
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
招募中1 期
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
招募中1/2 期
- Research Site, Chicago
A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
招募中1 期
- Northwestern Medicine, Chicago
MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
招募中1/2 期
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
招募中早期第 1 期歡迎健康志工
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
招募中2 期
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
招募中1/2 期
- Northwestern Memorial Hospital, Chicago
rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
招募中1 期
- Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
其他城市的 神經膠質瘤 試驗
- New York City, NY25 項研究
- Houston, TX23 項研究
- Boston, MA20 項研究
- Washington, DC19 項研究
- Philadelphia, PA16 項研究
- Columbus, OH15 項研究
- Miami, FL15 項研究
- San Francisco, CA14 項研究
- Durham, NC12 項研究
- Seattle, WA11 項研究
- Los Angeles, CA10 項研究
- St. Louis, MO10 項研究
Chicago 的其他研究
- 非小細胞肺癌61 項研究
- 乳癌58 項研究
- 癌症（所有類型）51 項研究
- 轉移性癌症45 項研究
- 前列腺癌45 項研究
- 肥胖症41 項研究
- 肺癌41 項研究
- 卵巢癌36 項研究
- 中風34 項研究
- 大腸直腸癌33 項研究
- 心臟衰竭31 項研究
- 過重28 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。